NFA
DMTX

Nationwide Fund Advisors’s Dimension Therapeutics, Inc DMTX Stock Holding History

Nationwide Fund Advisors’s Portfolio DMTX Stock Details DMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-7,468
Closed -$13K – 3372
2017
Q1 		$13K Sell
7,468
-12,025
-62% -$31.9K ﹤0.01% 3115
2016
Q4 		$85K Buy
19,493
+12,025
+161% +$64K ﹤0.01% 2916
2016
Q3 		$60K Hold
7,468
– – ﹤0.01% 3022
2016
Q2 		$45K Buy
7,468
+3,416
+84% +$26K ﹤0.01% 3092
2016
Q1 		$32K Buy
4,052
+1,263
+45% +$9.95K ﹤0.01% 3055
2015
Q4 		$31K Buy
+2,789
New +$35.3K ﹤0.01% 3044

Other funds holding DMTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Nationwide Fund Advisors's DMTX Position: Q2 2017 in Review

Nationwide Fund Advisors sold out of Dimension Therapeutics, Inc (DMTX) in Q2 2017, closing a stake of 7,468 shares — an estimated $13K sold.

Nationwide Fund Advisors first reported a position in DMTX in Q4 2015 and held it in 6 quarters. The position peaked at $85K in Q4 2016. 35 funds tracked by Wall St. Rank hold DMTX as of Q2 2017.

  • Nationwide Fund Advisors reported no remaining Dimension Therapeutics, Inc position as of Q2 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 7,468 Dimension Therapeutics, Inc shares in Q2 2017, an estimated $13K.
  • Nationwide Fund Advisors first reported a position in Dimension Therapeutics, Inc in Q4 2015 and held it in 6 quarters.
  • Nationwide Fund Advisors's Dimension Therapeutics, Inc position peaked at $85K in Q4 2016.
  • 35 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q2 2017.

Based on Nationwide Fund Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.